Copyright
©The Author(s) 2020.
World J Gastroenterol. May 21, 2020; 26(19): 2388-2402
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2388
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2388
Figure 4 Receiver operating characteristic curves in the training set.
A: Combined radiomics model [area under the curve (AUC) = 0.908, accuracy (ACC) = 0.812] achieved a better performance than individual computed tomography, dynamic contrast enhanced T1 images, high resolution T2-weighted imaging and apparent diffusion coefficient models; B: The extramural venous invasion model achieved relatively low performance in the training (AUC = 0.73, ACC = 0.714) set. In contrast, the multi-modal radiomics model (AUC = 0.925, ACC = 0.886) and combined radiomics model (AUC = 0.921, ACC = 0.886) performed better. CRM: Combined radiomics model; DCE-T1: Dynamic contrast enhanced T1 images; HR-T2WI: High resolution T2-weighted imaging; ADC: Apparent diffusion coefficient; CT: Computed tomography; MRM: Multi-modal radiomics model; EMVI: Extramural venous invasion.
- Citation: Li ZY, Wang XD, Li M, Liu XJ, Ye Z, Song B, Yuan F, Yuan Y, Xia CC, Zhang X, Li Q. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer. World J Gastroenterol 2020; 26(19): 2388-2402
- URL: https://www.wjgnet.com/1007-9327/full/v26/i19/2388.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i19.2388